JOSHUA VOCQUE: Open Payments
NPI 1831778174 · HENSLEY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 11 payments from 6 companies in 2025. Trend: 2023 $16 · 2024 $84 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $76 |
| Janssen Biotech, Inc. | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: TREMFYA, Qelbree, Wegovy, Rybelsus, BREZTRI, Ozempic, REXULTI, MOUNJARO.
Industry payments across AR — which companies pay providers there.
